Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397982
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2006-11-09
Brief Title:
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Sponsor:
Organization:
National Cancer Institute NCI